EQS — News: SPARX Global Randomized Controlled Trial by Translumina Initiated to Advance Evidence for Drug — Coated Balloons in Complex Coronary Disease
EQS-News: Translumina / Key word(s): Miscellaneous SPARX Global Randomized Controlled Trial by Translumina Initiated to Advance Evidence for Drug-Coated Balloons in Complex Coronary Disease 12.10.2026 / 20:05 CET/CEST The issuer is solely responsible for the content of this announcement. ═══════════════════════════════